how do glp 1 agonists work for diabetes GLP-1 receptor individualized treatment of type 2 mellitus GLP1 Receptor Agonists—Effects beyond Obesity

Description

Dubrow, who appears on the July 2, 2026 cover of of Womans World magazine, where he shares the latest on retatrutide and GLP-1 drugs

A randomized clinical trial comparing the effect of once-daily treatment of liraglutide and once-weekly treatment of semaglutide showed that adult patients treated with semaglutide for 68 weeks showed more than twice the decrease in body weight compared to people treated with liraglutide [80]

Current evidence supporting GLP-1 RAs applications in sleep disorders is outlined in Table 12

Cardiovascular protection: Some GLP-1 medications have been shown to reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular death in people with type 2 diabetes, particularly those with existing cardiovascular disease or multiple risk factors